British pharmaceutical company AstraZeneca said on May 7 that since the COVID-19 pandemic, there has been an excess of available vaccines, and the company has begun to remove the COVID-19 vaccine globally. AstraZeneca acknowledged in legal documents submitted to the court earlier this year that the company's vaccine “causes blood clots and thrombocytopenia in rare cases, and the mechanism of its pathogenesis is unclear,” but AstraZeneca said that the decision to remove the vaccine this time is unrelated to the court case or the company's admission that the vaccine may cause side effects for some vaccinators.
阿斯利康以供应过剩为由在全球下架新冠疫苗，并称与可能的副作用无关
AstraZeneca is removing the COVID-19 vaccine globally due to oversupply, and says it has nothing to do with possible side effects
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.